Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does APREPITANT Cause Thrombocytopenia? 194 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 194 reports of Thrombocytopenia have been filed in association with APREPITANT (CINVANTI). This represents 3.5% of all adverse event reports for APREPITANT.

194
Reports of Thrombocytopenia with APREPITANT
3.5%
of all APREPITANT reports
120
Deaths
147
Hospitalizations

How Dangerous Is Thrombocytopenia From APREPITANT?

Of the 194 reports, 120 (61.9%) resulted in death, 147 (75.8%) required hospitalization, and 104 (53.6%) were considered life-threatening.

Is Thrombocytopenia Listed in the Official Label?

Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for APREPITANT.

What Other Side Effects Does APREPITANT Cause?

Fatigue (955) Pyrexia (913) Dyspnoea (909) Hypersensitivity (881) Rash (789) Alopecia (760) Gastrointestinal disorder (722) Pruritus (707) Confusional state (696) Glossodynia (696)

What Other Drugs Cause Thrombocytopenia?

DEXAMETHASONE (5,873) RITUXIMAB (4,810) CYCLOPHOSPHAMIDE (4,669) LENALIDOMIDE (4,584) CARBOPLATIN (4,483) METHOTREXATE (3,865) DOXORUBICIN (3,638) ETOPOSIDE (3,085) VINCRISTINE (2,940) OXALIPLATIN (2,886)

Which APREPITANT Alternatives Have Lower Thrombocytopenia Risk?

APREPITANT vs APROTININ APREPITANT vs ARANESP APREPITANT vs ARAVA APREPITANT vs AREDIA APREPITANT vs ARFORMOTEROL

Related Pages

APREPITANT Full Profile All Thrombocytopenia Reports All Drugs Causing Thrombocytopenia APREPITANT Demographics